{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:31:42Z","timestamp":1648992702387},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"none"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12882-016-0270-2","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T01:11:44Z","timestamp":1465434704000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort study"],"prefix":"10.1186","volume":"17","author":[{"given":"Clotilde","family":"Muller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Messas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Olagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Gautier-Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelle","family":"Cognard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Caillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"issue":"5","key":"270_CR1","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/01.ASN.0000123691.46138.E2","volume":"15","author":"DE Weiner","year":"2004","unstructured":"Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15(5):1307\u201315.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"270_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","volume":"41","author":"G Manjunath","year":"2003","unstructured":"Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. JAC. 2003;41(1):47\u201355.","journal-title":"JAC"},{"issue":"12","key":"270_CR3","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.amjcard.2004.08.035","volume":"94","author":"R Dumaine","year":"2004","unstructured":"Dumaine R, Collet J-P, Tanguy M-L, Mansencal N, Dubois-Rand\u00e9 J-L, Henry P, et al. Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study). AJC. 2004;94(12):1543\u20137.","journal-title":"AJC"},{"issue":"22","key":"270_CR4","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.ehj.2004.08.016","volume":"25","author":"CM Gibson","year":"2004","unstructured":"Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, et al. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. Eur Heart J. 2004;25(22):1998\u20132005.","journal-title":"Eur Heart J"},{"issue":"9","key":"270_CR5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/heart.89.9.1003","volume":"89","author":"JJ Santopinto","year":"2003","unstructured":"Santopinto JJ, Fox KAA, Goldberg RJ, Budaj A, Pi\u00f1ero G, Avezum A, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003;89(9):1003\u20138.","journal-title":"Heart"},{"issue":"13","key":"270_CR6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296\u2013305.","journal-title":"N Engl J Med"},{"issue":"5","key":"270_CR7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/ki.2008.233","volume":"75","author":"SP Surana","year":"2008","unstructured":"Surana SP, Riella LV, Keithi-Reddy SR, Charytan DM, Singh AK. Acute coronary syndrome in ESRD patients. Kidney Int. 2008;75(5):558\u201362.","journal-title":"Kidney Int"},{"issue":"7","key":"270_CR8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","volume":"39","author":"PJM Best","year":"2002","unstructured":"Best PJM, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. JAC. 2002;39(7):1113\u20139.","journal-title":"JAC"},{"issue":"10","key":"270_CR9","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.amjcard.2003.07.023","volume":"92","author":"SS Naidu","year":"2003","unstructured":"Naidu SS, Selzer F, Jacobs A, Faxon D, Marks DS, Johnston J, et al. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. AJC. 2003;92(10):1160\u20134.","journal-title":"AJC"},{"issue":"14","key":"270_CR10","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","volume":"49","author":"DJ Angiolillo","year":"2007","unstructured":"Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol. 2007;49(14):1505\u201316.","journal-title":"J Am Coll Cardiol"},{"key":"270_CR11","doi-asserted-by":"crossref","unstructured":"Kolh P, Windecker S. ESC\/EACTS myocardial revascularization guidelines 2014. Eur Heart J. 2014;35(46):3235\u20136.","DOI":"10.1093\/ejcts\/ezu366"},{"key":"270_CR12","unstructured":"Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Bl\u00f6mstrom-Lundqvist C, et al. ESCGuidelines for the management of acute myocardial infarction in patients presenting with ST-segmentelevation. Eur Heart J. 2012;33(20):2569\u2013619."},{"issue":"3","key":"270_CR13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1538-7836.2005.01751.x","volume":"4","author":"T Cuisset","year":"2006","unstructured":"Cuisset T, Frere C, Quilici J, Barbou F, Morange PE, Hovasse T, et al. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost. 2006;4(3):542\u20139.","journal-title":"J Thromb Haemost"},{"issue":"20","key":"270_CR14","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehl275","volume":"27","author":"T Geisler","year":"2006","unstructured":"Geisler T, Langer H, Wydymus M, G\u00f6hring K, Z\u00fcrn C, Bigalke B, et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J. 2006;27(20):2420\u20135.","journal-title":"Eur Heart J"},{"issue":"9","key":"270_CR15","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jacc.2006.06.065","volume":"48","author":"W Hochholzer","year":"2006","unstructured":"Hochholzer W, Trenk D, Bestehorn H-P, Fischer B, Valina CM, Ferenc M, et al. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol. 2006;48(9):1742\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"270_CR16","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jacc.2007.01.094","volume":"49","author":"P Buonamici","year":"2007","unstructured":"Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol. 2007;49(24):2312\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"270_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","volume":"119","author":"R Marcucci","year":"2009","unstructured":"Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, et al. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Circulation. 2009;119(2):237\u201342.","journal-title":"Circulation"},{"issue":"25","key":"270_CR18","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.jacc.2010.12.047","volume":"57","author":"G Campo","year":"2011","unstructured":"Campo G, Parrinello G, Ferraresi P, Lunghi B, Tebaldi M, Miccoli M, et al. Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. J Am Coll Cardiol. 2011;57(25):2474\u201383.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"270_CR19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jacc.2010.09.032","volume":"57","author":"O Morel","year":"2011","unstructured":"Morel O, El Ghannudi S, Jesel L, Radulescu B, Meyer N, Wiesel M-L, et al. Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. J Am Coll Cardiol. 2011;57(4):399\u2013408.","journal-title":"J Am Coll Cardiol"},{"key":"270_CR20","doi-asserted-by":"crossref","unstructured":"Muller C, Caillard S, Jesel L, Ghannudi El S, Ohlmann P, Sauleau E, et al. Association of estimated GFR with platelet inhibition in patients treated with clopidogrel. Am J Kidney Dis. 2012;59(6):777\u201385.","DOI":"10.1053\/j.ajkd.2011.12.027"},{"issue":"1 Suppl 1","key":"270_CR21","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2012.11.031","volume":"61","author":"AJ Collins","year":"2013","unstructured":"Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, et al. US renal data system 2012 annual data report. Am J Kidney Dis. 2013;61(1 Suppl 1):A7. \u2013e1\u2013476.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"270_CR22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.amjsurg.2014.06.007","volume":"208","author":"JM Williams","year":"2014","unstructured":"Williams JM, Tuttle-Newhall JE, Schnitzler M, Dzebisashvili N, Xiao H, Axelrod D, et al. Clopidogrel use as a risk factor for poor outcomes after kidney transplantation. Am J Surg. 2014;208(4):556\u201362.","journal-title":"Am J Surg"},{"issue":"3","key":"270_CR23","first-page":"218","volume":"76","author":"G Sahin","year":"2011","unstructured":"Sahin G, Akay OM, Bal C, Yalcin AU, Gulbas Z. The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients. Clin Nephrol. 2011;76(3):218\u201325.","journal-title":"Clin Nephrol"},{"issue":"5","key":"270_CR24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clpt.2005.08.002","volume":"78","author":"J Graff","year":"2005","unstructured":"Graff J, Harder S, Wahl O, Scheuermann E-H, Gossmann J. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers. Clin Pharmacol Ther. 2005;78(5):468\u201376.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"270_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1538-7836.2004.01063.x","volume":"3","author":"B Aleil","year":"2005","unstructured":"Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost. 2005;3(1):85\u201392.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"270_CR26","first-page":"648","volume":"3","author":"SE Ghannudi","year":"2010","unstructured":"Ghannudi SE, Ohlmann P, Meyer N, Wiesel ML, Radulescu B, Chauvin M, et al. Impact of P2Y12 inhibition by clopidogrel on cardiovascular mortality in unselected patients treated by percutaneous coronary angioplasty. JCIN Elsevier Inc. 2010;3(6):648\u201356.","journal-title":"JCIN Elsevier Inc"},{"issue":"4","key":"270_CR27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1536\/ihj.13-367","volume":"55","author":"J Shiraishi","year":"2014","unstructured":"Shiraishi J, Kohno Y, Nakamura T, Yanagiuchi T, Hashimoto S, Ito D, et al. Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Int Heart J. 2014;55(4):301\u20136.","journal-title":"Int Heart J"},{"issue":"7","key":"270_CR28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.amjcard.2013.12.018","volume":"113","author":"F Mangiacapra","year":"2014","unstructured":"Mangiacapra F, Cavallari I, Barbato E, Ricottini E, Patti G, Vizzi V, et al. Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary intervention. Am J Cardiol. 2014;113(7):1124\u20139.","journal-title":"Am J Cardiol"},{"issue":"6","key":"270_CR29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1053\/j.ajkd.2012.01.016","volume":"59","author":"EH Bae","year":"2012","unstructured":"Bae EH, Lim SY, Cho KH, Choi JS, Kim CS, Park JW, et al. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis. 2012;59(6):795\u2013802.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"270_CR30","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1253\/circj.CJ-12-0173","volume":"76","author":"D Alexopoulos","year":"2012","unstructured":"Alexopoulos D, Xanthopoulou I, Tsigkas G, Damelou A, Theodoropoulos KC, Kassimis G, et al. Predictors of high on-treatment platelet reactivity early after clopidogrel loading in ST-elevation myocardial infarction. Circ J. 2012;76(9):2183\u20137.","journal-title":"Circ J"},{"issue":"4","key":"270_CR31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1681\/ASN.2010020220","volume":"22","author":"P Htun","year":"2011","unstructured":"Htun P, Fateh-Moghadam S, Bischofs C, Banya W, Muller K, Bigalke B, et al. Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention. J Am Soc Nephrol. 2011;22(4):627\u201333.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"270_CR32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.amjcard.2007.02.081","volume":"100","author":"D Sibbing","year":"2007","unstructured":"Sibbing D, von Beckerath O, Sch\u00f6mig A, Kastrati A, von Beckerath N. Impact of body mass index on platelet aggregation after administration of a high loading dose of 600\u00a0mg of clopidogrel before percutaneous coronary intervention. AJC. 2007;100(2):203\u20135.","journal-title":"AJC"},{"issue":"2","key":"270_CR33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1160\/TH11-12-0876","volume":"108","author":"O Morel","year":"2012","unstructured":"Morel O, El Ghannudi S, Hess S, Reydel A, Crimizade U, Jesel L, et al. The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: roles of white blood cell count and body weight. Thromb Haemost. 2012;108(2):338\u201348.","journal-title":"Thromb Haemost"},{"issue":"5","key":"270_CR34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.tp.0000235527.81917.fe","volume":"82","author":"AO Ojo","year":"2006","unstructured":"Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation. 2006;82(5):603\u201311.","journal-title":"Transplantation"},{"issue":"2","key":"270_CR35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/TP.0b013e318160254f","volume":"85","author":"YFC Vanrenterghem","year":"2008","unstructured":"Vanrenterghem YFC, Claes K, Montagnino G, Fieuws S, Maes B, Villa M, et al. Risk factors for cardiovascular events after successful renal transplantation. Transplantation. 2008;85(2):209\u201316.","journal-title":"Transplantation"},{"issue":"11","key":"270_CR36","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1600-6143.2008.02414.x","volume":"8","author":"AJ Matas","year":"2008","unstructured":"Matas AJ, Gillingham KJ, Humar A, Kandaswamy R, Sutherland DER, Payne WD, et al. 2202 kidney transplant recipients with 10\u00a0years of graft function: what happens next? Am J Transplant. 2008;8(11):2410\u20139.","journal-title":"Am J Transplant"},{"issue":"3","key":"270_CR37","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/ndt\/14.3.648","volume":"14","author":"S Aakhus","year":"1999","unstructured":"Aakhus S, Dahl K, Wider\u00f8e TE. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant. 1999;14(3):648\u201354.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"270_CR38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1067\/mcp.2002.127115","volume":"72","author":"J Graff","year":"2002","unstructured":"Graff J, Klinkhardt U, Harder S, Wegert W, Lenz T, Scheuermann E-H, et al. Immunosuppressive therapy regimen and platelet activation in renal transplant patients. Clin Pharmacol Ther. 2002;72(4):411\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"270_CR39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1160\/TH14-03-0238","volume":"113","author":"JM Siller-Matula","year":"2015","unstructured":"Siller-Matula JM, Trenk D, Schr\u00f6r K, Gawaz M, Kristensen SD, Storey RF, et al. How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors--is an algorithm the answer? Thromb Haemost. 2015;113(1):37\u201352.","journal-title":"Thromb Haemost"},{"issue":"1","key":"270_CR40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jth.12445","volume":"12","author":"JM Siller-Matula","year":"2014","unstructured":"Siller-Matula JM, Trenk D, Kr\u00e4henb\u00fchl S, Michelson AD, Delle-Karth G. Clinical implications of drug-drug interactions with P2Y12 receptor inhibitors. J Thromb Haemost. 2014;12(1):2\u201313.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"270_CR41","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.109.933796","volume":"122","author":"S James","year":"2010","unstructured":"James S, Budaj A, Aylward P, Buck KK, Cannon CP, Cornel JH, et al. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation. 2010;122(11):1056\u201367.","journal-title":"Circulation"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-016-0270-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T11:39:21Z","timestamp":1568029161000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-016-0270-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["270"],"URL":"https:\/\/doi.org\/10.1186\/s12882-016-0270-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]},"article-number":"58"}}